Legal Representation
Attorney
Hope V. Shovein
USPTO Deadlines
Next Deadline
64 days remaining
Final Refusal E-Mailed
Due Date
September 30, 2025
Extension Available
Until December 30, 2025
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 30, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 30, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 30, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jun 30, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Dec 30, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 9, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 2, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 31, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 31, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 31, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 13, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 12, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 12, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 10, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 10, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 10, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 16, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 15, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 6, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
diagnostic reagents for clinical or medical purposes; diagnostic reagents for clinical medical purposes
First Use Anywhere:
20190000
First Use in Commerce:
20190000
Additional Information
Design Mark
The mark consists of a triangle design comprised of diagonal lines followed by the word POINTE.
Other
The mark was first used anywhere in a different form other than that sought to be registered at least as early as 00/00/1981
Other
The mark was first used in commerce in a different form other than that sought to be registered at least as early as 00/00/1981
Pseudo Mark
POINT
Pseudo Mark
TIP
Classification
International Classes
005